HIGHLIGHTS
- who: Sonia Simu00f3n Serrano and colleagues from the Translational Cancer Research, Department of Laboratory Medicine, University, Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA have published the research work: Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma, in the Journal: Cancers 2022, 4553 of 15/Nov/2017
- what: The authors aimed to evaluate changes in the gene expression of HCC cells caused by inhibition to explore suitable combination treatment approaches including the use of chemoagents such as cisplatin. The authors aimed to further investigate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.